Western blot results showed that Exo-GPR37 exerted its effect on ESCC cells through the AKT/mTOR signaling pathway (Fig. 8L and Supplementary Fig. 9J). The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.